The global Point-of-Care Testing (POCT) Market is experiencing significant growth due to advancements in medical technology, increasing demand for rapid diagnostics, and a rise in chronic diseases. PoCT allows for quick results at the patient’s location, improving patient outcomes and reducing healthcare costs. Key drivers include the growing focus on personalized medicine, aging populations, and the convenience of home testing. Moreover, innovations in mobile health (mHealth) and wearable devices are shaping the market. North America holds the largest market share, while Asia Pacific is expected to witness the fastest growth due to rising healthcare infrastructure and demand.
Frequently Asked Questions
U.S. is expected to dominate the global point-of-care testing (POCT) market due to advanced healthcare infrastructure, high demand for rapid diagnostics, significant investment in R&D, and regulatory support for innovative medical technologies.
Asia-Pacific is expected to dominate the global point-of-care testing (POCT) market due to its well-established healthcare infrastructure, high disposable income, and strong presence of product manufacturers.
India is the fastest-growing country in the POCT market, driven by increasing healthcare access, rising chronic disease prevalence, government initiatives, and growing demand for affordable, rapid diagnostics in rural areas.
The glucose monitoring products segment is expected to dominate the global point-of-care testing (POCT) market holding a major market share in 2025.
